Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Great Dispersion in the Prognosis of Patients with Angina and No Coronary Lesions

The prognosis of patients with symptoms of angina (with all their subjectivity) in a setting of no significant coronary lesions is widely varied. It is not as benign as we initially thought and patients do not present as many events as “regular” patients with associated severe coronary lesions.

infarto peri-procedimientoThe literature owed us data on the long-term prognosis for these patients and that is precisely the subject matter of this work that was recently published in the European Heart Journal.

 

The authors searched for studies published on the subject up to 2017 that included the events all-cause death and nonfatal infarction. This meta-analysis included 54 studies with a total of 35,039 patients (mean age 56 years, male/female ratio: 0.51), all of them with typical angina symptoms and no significant coronary lesions.


Read also: The Crucial Significance of Lifestyle Changes.


After a 5-year follow-up (range: 3 to 7 years), the pooled global incidence of death and infarction was 0.98/100 person-years, with considerable heterogeneity among studies (p < 0.001).

 

The primary endpoint was associated with the presence of dyslipidemia (p = 0.016), diabetes (p = 0.035), and hypertension (p = 0.016). Studies enrolling patients with non-obstructive or non-significant coronary lesions, in angiographic terms, showed more events (1.32/100 person-years) than studies including only patients with entirely normal coronary arteries (0.52/100 person-years). However, there were no differences between studies enrolling patients with documented myocardial ischemia and studies that did not contemplate this pathology as a variable in the protocol.

 

In any case, ischemia documented by non-invasive imaging techniques was associated with a higher rate of events (p = 0.02).


Read also: Are Abdominal Aortic Aneurysm Screening Programs Overstated?


The Achilles’ heel for these patients is definitely the high rate of recurrent hospitalization due to angina, which often results in catheterization confirming the results of prior catheterizations: coronary arteries with no angiographically significant lesions.

 

Conclusion

The prognosis for patients with angina without significant lesions is heterogeneous. The main determinant of adverse events is the presence of “some” atherosclerosis and positive functional tests for ischemia in any area. The quality of life of these patients is affected by the high incidence of hospitalization, recurrent angina, and repeated catheterizations.

 

Original title: Determinants of Long-Term Clinical Outcomes in Patients with Angina but Without Obstructive Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Reference: Francesco Radico et al. Eur Heart J. 2018 Jun 14;39(23):2135-2146.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...